CD47 is a glycoprotein widely expressed in tumor cells and is highly expressed in patients with various cancers, including HCC, breast cancer, glioblastoma, lung cancer, colorectal cancer, and ovarian cancer. This evidence concerns the gene CD47 and breast carcinoma.